Botulinum toxin A (Daewoong Pharmaceuticals)

A型肉毒毒素（大熊制药）

Report date: 2026/03/19 20:00:18

Base Information

Drug NameBotulinum toxin A (Daewoong Pharmaceuticals)
Drug Alias NameprabotulinumtoxinA-xvfsPrabotulinumtoxin ANabotaNuceivaJeuveau +[8] 
ClassificationBiologics > Protein drugs > ToxinNatural product/Extract > Microbial extract
Mechanisms of ActionSynaptosomal-associated protein 25 inhibitors
TargetsSynaptosomal-associated protein 25
Therapy Area/IndicationsNasolabial fold wrinklesGlabellar linesBlepharospasm +[8] 
Global Approved IndicationsNasolabial fold wrinklesGlabellar lines
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2013/01/01
Country/TerritoryCanadaUnited StatesAustralia +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesValentech Pharma Colombia SASMontana Marketing LtdDaewoong Pharmaceutical Co Ltd +[6] 
Inactive CompaniesBeijing Daewoong Pharmaceutical R&D Center Co Ltd
Active IndicationsNasolabial fold wrinklesGlabellar linesTorticollis +[5] 
Inactive IndicationsBlepharospasmStrokeMuscle Spasticity

Other Information

ATC CodeM03AX01
Related LinksDrugBank